BMC Veterinary Research

Table 2 List of treatments and immunization does

From: In vivo immunogenicity assessment and vaccine efficacy evaluation of a chimeric tandem repeat of epitopic region of OMP31 antigen fused to interleukin 2 (IL-2) against Brucella melitensis in BALB/c mice

	T1	T2	T3	T4	T5	T6	T7	T7	T9	T10	T11	T12	T13
Treatments	OMP31	IL-2	3E	OMP-IL2	OMP+IL2	3E-IL2	3E+IL2	OMP-IL2+ IFA	OMP+ IFA	Rev1	LPS^a	IFA	PBS
Dose of injection	30μg	30μg	30μg	30μg	30μg+30μg	30μg	30μg+30μg	30μg	30μg	1dose	100μl	100μl	100μl

^aThis treatment contains an extract of the periplasmic part of the BL21 (DE3) bacterium which may contains bacterial lipopolysaccharide (LPS)

Back to article page

ISSN: 1746-6148

Contact us

General enquiries: journalsubmissions@springernature.com